Every material Form 8-K Aimei Health Technology Co., Ltd. has filed with the SEC since September 03, 2026, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
Aimei Health Technology Co., Ltd. deposited $34,330.96 into its trust account to extend the deadline to complete its initial business combination by one month, from November 6, 2026 to December 6, 2026. The company funded the payment with an unsecured, non-interest-bearing promissory note to Aimei Investment Ltd, which becomes due only at the business combination, so the extension adds to the company's obligations for public shareholders.
Extension Payment of $34,330.96 is the lesser of $80,000 or $0.033 per outstanding public share for each monthly extension.
Termination date moves from November 6, 2026 to December 6, 2026; the filing describes this as the twenty-fourth extension.
Promissory note dated November 5, 2026, issued to Aimei Investment Ltd, is convertible at the payee's option into private units at $10.00 per unit.
Aimei Health Technology Co., Ltd. extended the deadline to complete its business combination with United Hydrogen by one month, from October 6, 2026 to November 6, 2026. The extension was funded by an unsecured, non-interest-bearing promissory note of $34,330.96 issued to Aimei Investment Ltd, which becomes due at the business combination closing or can be converted into private units.
Extension payment of $34,330.96 deposited into the trust account, the twenty-third extension permitted under the articles
New deadline to consummate the business combination is November 6, 2026, up from October 6, 2026
Promissory note issued October 5, 2026 to Aimei Investment Ltd, non-interest-bearing, due at closing of the United Hydrogen business combination
Aimei Health Technology Co., Ltd. deposited $34,330.96 into its trust account to extend its deadline to complete a business combination from September 6, 2026 to October 6, 2026, and issued an unsecured, non-interest-bearing promissory note to fund the payment. The note is due only upon closing of the planned business combination with United Hydrogen, and the payee may convert it into private units at $10.00 each.
Extension payment of $34,330.96, the lesser of $80,000 total or $0.033 per public share
Termination date moves from September 6, 2026 to October 6, 2026; this is the 22nd extension permitted
Promissory note issued September 3, 2026 to Aimei Investment Ltd, with no interest and principal due at the business combination with United Hydrogen
Payee may convert the note into private units at $10.00 per unit, each with one ordinary share and one right to one-fifth of a share
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every Aimei Health Technology Co., Ltd. filing is on SEC EDGAR ↗. 8-K briefs of other companies →